Assignee
PROGENRA INC
US·4 granted patents·3 pending applications·16 citations·filing 2005–2018
Top patents by PatentIndex Score
7 records- 0190US9717717B1Methods of treating cancer through the inhibition of USP7 and immune system modulationPROGENRA INC·Filed 2016·Granted Aug 1, 2017·9 cites·18 claims
- 0271US7842460B2Method for assessing proteolytic enzyme activity using ubiquitin fusion substratePROGENRA INC·Filed 2005·Granted Nov 30, 2010·7 cites·25 claims
- 0350US11273154B2Azole compounds as ubiquitin-specific protease USP7 inhibitorsPROGENRA INC·Filed 2018·Granted Mar 15, 2022·0 cites·10 claims
- 0449US2010021941A1Methods of identifying modulators of ubiquitin ligasesPROGENRA INC·Filed 2009·Application pending·0 cites
- 0545US10292973B2Covalent irreversible inhibitors of USP7 as anti-cancer agentsPROGENRA INC·Filed 2016·Granted May 21, 2019·0 cites·27 claims
- 0641US2014309141A1Methods of Screening for Inhibitors of EnzymesPROGENRA INC·Filed 2012·Application pending·0 cites
- 0738US2013273027A1Mutant proteases and methods of use thereofPROGENRA INC·Filed 2013·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →